Nicotinamide Riboside Protected Mitochondria in Mice With a Rare Muscle Disease
Graded Preliminary — eight-week supplementation study in NEM6 knock-in mice, number not specified, so the effect has not yet been shown in people.
- Design
- —
- Participants
- 6
- Duration
- —
- Funding
- —
This early animal study supports NR's role in supporting NAD+ levels and muscle mitochondria.
NR, a popular NAD+ booster, kept muscle cell powerhouses working in mice with a rare genetic muscle disorder. The disease drains NAD+ levels and damages how muscles make energy. Starting NR early stopped this damage from setting in. This is early animal work tied to a specific inherited condition, not healthy people.
Disclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.